Journal Article Summary
The article examines the management of cholera infection in children, specifically focusing on the need for updated treatment guidelines. Cholera, caused by the bacterium Vibrio cholerae, leads to millions of cases of severe diarrhea and significant mortality, particularly in children. The World Health Organization's existing treatment recommendations are based on outdated data, and with rising antibiotic resistance, there is an urgent need to reassess the most effective and safe treatment options for pediatric patients.
The authors conducted a systematic review of the literature to evaluate current treatment practices for cholera in children, analyzing studies published over the last decade. They found that while traditional treatments like tetracycline are still used, increasing resistance to this and other antibiotics has been documented. The review concluded that single-dose azithromycin (20 mg/kg) is a more effective and safer first-line treatment for pediatric cholera, with erythromycin as a second-line option. Fluid resuscitation remains a critical component of managing cholera, emphasizing the importance of rehydration in treatment.
Despite the valuable insights provided, the study has limitations, including the quality of the included studies, which varied significantly. Patients and caregivers should be aware of the potential risks associated with antibiotic use, such as adverse effects and the development of resistance. It is essential for readers to discuss any concerns or treatment options with a healthcare professional, especially in areas where cholera is prevalent, to ensure the best care and management strategies are employed.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Williams Phoebe C. M., Berkley James A.. Guidelines for the management of paediatric cholera infection: a systematic review of the evidence. Paediatrics and International Child Health 2018. DOI: 10.1080/20469047.2017.1409452. PMID: 29790841. PMCID: PMC5972638.
Featured Pill Pals Product
Azithromycin 250 mg Tablet Six (6) Pack --- TEVA Pharma --- Generic For Z Pack / Zithromax
Azithromycin 250 mg Tablet Six (6) Pack — TEVA Pharma — Generic For Z Pack / Zithromax is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
